Rovalpituzumab Tesirine: A Novel DLL3-Targeting Antibody–Drug Conjugate

Por Bilal H. Lashari, Yazhini Vallatharasu, Lakshmi Kolandra, Mohsin Hamid, Dipesh Uprety
Publicado em 2018-09-01